Direct Healthcare Professional Communication: AmBisome Liposomal 50 mg Powder for dispersion for infusion (PL 16807/0001)- identify and dispose of co-packaged Sartorius 5μm Minisart Filters due to potential to release fibres during use

The release of fibres and particles into the infusion could pose a risk of causing thromboembolism in the patient receiving liposomal amphotericin. There is no quality issue associated with AmBisome product and due to supply considerations, the product is not being recalled.

Source:

Gilead Sciences Ltd